Literature DB >> 23332921

Common genetic risk factors for venous thrombosis in the Chinese population.

Liang Tang1, Hua-Fang Wang, Xuan Lu, Xiao-Rong Jian, Bi Jin, Hong Zheng, Yi-Qing Li, Qing-Yun Wang, Tang-Chun Wu, Huan Guo, Hui Liu, Tao Guo, Jian-Ming Yu, Rui Yang, Yan Yang, Yu Hu.   

Abstract

Venous thrombosis is a major medical disorder caused by both genetic and environmental factors. Little is known about the genetic background of venous thrombosis in the Chinese population. A total of 1,304 individuals diagnosed with a first venous thrombosis and 1,334 age- and sex-matched healthy participants were enrolled in this study. Resequencing of THBD (encoding thrombomodulin) in 60 individuals with venous thrombosis and 60 controls and a functional assay showed that a common variant, c.-151G>T (rs16984852), in the 5' UTR significantly reduced the gene expression and could cause a predisposition to venous thrombosis. Therefore, this variant was genotyped in a case-control study, and results indicated that heterozygotes had a 2.80-fold (95% confidence interval = 1.88-4.29) increased risk of venous thrombosis. The THBD c.-151G>T variant was further investigated in a family analysis involving 176 first-degree relatives from 38 index families. First-degree relatives with this variant had a 3.42-fold increased risk of venous thrombosis, and their probability of remaining thrombosis-free was significantly lower than that of relatives without the variant. In addition, five rare mutations that might be deleterious were also identified in thrombophilic individuals by sequencing. This study is the largest genetic investigation of venous thrombosis in the Chinese population. Further study on genetics of thrombosis should focus on resequencing of THBD and other hemostasis genes in different populations.
Copyright © 2013 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23332921      PMCID: PMC3567266          DOI: 10.1016/j.ajhg.2012.12.013

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  60 in total

1.  Prediction of both conserved and nonconserved microRNA targets in animals.

Authors:  Xiaowei Wang; Issam M El Naqa
Journal:  Bioinformatics       Date:  2007-11-29       Impact factor: 6.937

Review 2.  Advances in understanding pathogenic mechanisms of thrombophilic disorders.

Authors:  Björn Dahlbäck
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

3.  Haplotype of thrombomodulin gene associated with plasma thrombomodulin level and deep vein thrombosis in the Japanese population.

Authors:  Shoko Sugiyama; Hisao Hirota; Rina Kimura; Yoshihiro Kokubo; Tomio Kawasaki; Etsuji Suehisa; Akira Okayama; Hitonobu Tomoike; Tokio Hayashi; Kazuhiro Nishigami; Ichiro Kawase; Toshiyuki Miyata
Journal:  Thromb Res       Date:  2006-02-28       Impact factor: 3.944

4.  Thrombomodulin gene mutations associated with myocardial infarction.

Authors:  H Ireland; G Kunz; K Kyriakoulis; P J Stubbs; D A Lane
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

5.  Mutations in promoter region of thrombomodulin and venous thromboembolic disease.

Authors:  L Le Flem; V Picard; J Emmerich; S Gandrille; J N Fiessinger; M Aiach; M Alhenc-Gelas
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

6.  Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.

Authors:  J A Heit; J M Cunningham; T M Petterson; S M Armasu; D N Rider; M DE Andrade
Journal:  J Thromb Haemost       Date:  2011-06       Impact factor: 5.824

Review 7.  Venous thrombosis: a multicausal disease.

Authors:  F R Rosendaal
Journal:  Lancet       Date:  1999-04-03       Impact factor: 79.321

8.  Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study.

Authors:  N Aleksic; A R Folsom; M Cushman; S R Heckbert; M Y Tsai; K K Wu
Journal:  J Thromb Haemost       Date:  2003-01       Impact factor: 5.824

Review 9.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

10.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study.

Authors:  T Koster; F R Rosendaal; H de Ronde; E Briët; J P Vandenbroucke; R M Bertina
Journal:  Lancet       Date:  1993 Dec 18-25       Impact factor: 79.321

View more
  22 in total

1.  Whole-exome sequencing in evaluation of patients with venous thromboembolism.

Authors:  Eun-Ju Lee; Daniel J Dykas; Andrew D Leavitt; Rodney M Camire; Eduard Ebberink; Pablo García de Frutos; Kavitha Gnanasambandan; Sean X Gu; James A Huntington; Steven R Lentz; Koen Mertens; Christopher R Parish; Alireza R Rezaie; Peter P Sayeski; Caroline Cromwell; Noffar Bar; Stephanie Halene; Natalia Neparidze; Terri L Parker; Adrienne J Burns; Anne Dumont; Xiaopan Yao; Cassius Iyad Ochoa Chaar; Jean M Connors; Allen E Bale; Alfred Ian Lee
Journal:  Blood Adv       Date:  2017-06-29

2.  Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort.

Authors:  Hui Shi; Jia-Lin Teng; Yue Sun; Xin-Yao Wu; Qiong-Yi Hu; Hong-Lei Liu; Xiao-Bing Cheng; Yu-Feng Yin; Jun-Na Ye; Pojen P Chen; Cheng-de Yang
Journal:  Clin Rheumatol       Date:  2017-01-27       Impact factor: 2.980

Review 3.  Progress in research into the genes associated with venous thromboembolism.

Authors:  Lian-Xing Zhao; Bo Liu; Chun-Sheng Li
Journal:  World J Emerg Med       Date:  2015

4.  Antithrombin deficiency and decreased protein C activity in a young man with venous thromboembolism: a case report.

Authors:  Dong Wang; Min Tian; Guanglin Cui; Dao Wen Wang
Journal:  Front Med       Date:  2017-08-31       Impact factor: 4.592

5.  Thrombophilia Caused by Beta2-Glycoprotein I Deficiency: In Vitro Study of a Rare Mutation in APOH Gene.

Authors:  Xiao-Ping Zhang; Wei Zeng; Hui Liu; Liang Tang; Qing-Yun Wang; Zhi-Peng Cheng; Ying-Ying Wu; Bei Hu; Wei Shi; Yu Hu
Journal:  Curr Med Sci       Date:  2018-04-30

Review 6.  Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians.

Authors:  Tong Yin; Toshiyuki Miyata
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

7.  Benefits may not outweigh risks of low molecular weight heparin (LMWH) in early postoperative thromboprophylaxis following minimally invasive cardiac surgery: a propensity score-matched analysis.

Authors:  Wei Li; Pei Wang; Shiguan Le; Wang Xi; Jing Wang; Liang Yin; Qing Wang; Yufeng Zhang; Zhinong Wang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

8.  APOC3 may not be a predictor of risk of ischemic vascular disease in the Chinese population.

Authors:  Liang Tang; Zhi-Peng Cheng; Qing-Yun Wang; Wei Zeng; Hui Liu; Ying-Ying Wu; Bei Hu; Yu Hu
Journal:  F1000Res       Date:  2014-11-07

9.  Hereditary protein S deficiency leads to ischemic stroke.

Authors:  Zhao-Hui Wang; Zhi-Jun Zhao; Kang Xu; Guo-Bing Sun; Lin Song; Hong-Xiang Yin; Xiao-Qi Chen
Journal:  Mol Med Rep       Date:  2015-05-18       Impact factor: 2.952

10.  Retinal artery and vein thrombotic occlusion during pregnancy: markers for familial thrombophilia and adverse pregnancy outcomes.

Authors:  Will S Kurtz; Charles J Glueck; Robert K Hutchins; Robert A Sisk; Ping Wang
Journal:  Clin Ophthalmol       Date:  2016-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.